The first case of Mpox infection in Iran during the 2022 outbreak

Ali Maleki1, Arash Arashkia2, Mohammad Hassan Pouriayevali3

  • 1COVID-19 National Reference Laboratory (CNRL), Pasteur Institute of Iran, Tehran, Iran.

Abstract

Insights

The first documented case of Mpox in an Iranian woman, infected by her traveling husband, highlights the global spread of this re-emerging infectious disease. Health systems must remain vigilant for timely identification and preparedness against outbreaks like Mpox.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • The global emergence of human Mpox (formerly monkeypox) cases in non-endemic countries, starting in May 2022 during the COVID-19 pandemic.
  • Increased human-to-human transmission capacity of the re-emerging Mpox virus, facilitated by international travel.
  • The need to document and understand Mpox transmission dynamics in diverse geographical and demographic contexts.

Observation:

  • Description of the first Mpox case identified in an Iranian woman.
  • The patient presented with flu-like symptoms and characteristic skin rashes on her extremities.
  • Transmission occurred within a household, with the index case being her husband who had recently traveled internationally.

Findings:

  • Diagnostic confirmation of Mpox infection using RT-PCR and Sanger sequencing on oropharyngeal and rash samples.
  • The case involved a 34-year-old woman with no prior history of Mpox.
  • Supportive care was administered, and no antiviral treatments were prescribed during her recovery.

Implications:

  • Emphasizes the global risk of infectious disease outbreaks, including Mpox, in the post-COVID-19 era.
  • Highlights the critical importance of robust health system surveillance for early detection and response to emerging pathogens.
  • Underscores the need for preparedness strategies to manage and contain outbreaks of diseases with pandemic potential.
Keywords:
IranMPXVMpox